PT Indofarma Tbk (IDX:INAF)

Revenue by Segment

Financials in millions IDR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Medical Devices & Others	104.22B	181.53B	424.22B	802.10B	849.73B
Medical Devices & Others Growth	-42.59%	-57.21%	-47.11%	-5.60%	34.15%
Medicine	106.16B	342.07B	556.15B	2.10T	865.86B
Medicine Growth	-68.97%	-38.49%	-73.52%	142.52%	19.30%
Total	210.38B	523.60B	980.37B	2.90T	1.72T
Total Growth	-59.82%	-46.59%	-66.22%	69.15%	26.22%

Revenue by Geography

Financials in millions IDR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Indonesia	195.51B	501.66B	965.95B	2.90T	1.70T
Indonesia Growth	-61.03%	-48.07%	-66.63%	70.58%	26.21%
Export	14.87B	21.94B	14.42B	6.89B	18.33B
Export Growth	-32.20%	52.13%	109.22%	-62.40%	27.11%
Total	210.38B	523.60B	980.37B	2.90T	1.72T
Total Growth	-59.82%	-46.59%	-66.22%	69.15%	26.22%

Source: S&P Global Market Intelligence.